1-3 of 3
Alexandr A Myasnikov
Close
Sort by
Journal Articles

Four Strategies of Autologous Hematopoietic Stem Cell Transplantation for Multiple Sclerosis Treatment

Andrei A. Novik, MD, FRCP, Boris V Afanasyev, Igor A Lisukov, Oleg A Rykavicin, Alexandr A Myasnikov, Tatiana I Ionova, Vladimir Y Melnichenko, Denis A Fedorenko, Nina E Osipova, Artur E Zdorov, Ruslana V Kruglina, Anton V Kishtovich, Roman I Ivanov, Gary J Gorodokin
Journal: Blood
Blood (2008) 112 (11): 4432.
https://doi.org/10.1182/blood.V112.11.4432.4432
Published: 2008
Journal Articles

Which Strategy of Immunoablative Therapy with Autologous Stem Cell Transplantation (ASCT) Is Preferable in Multiple Sclerosis (MS) Patients?.

Yury L. Shevchenko, Andrei A. Novik, Alexey N. Kuznetcov, Boris A. Afanasiev, Igor A. Lisukov, Oleg A. Rykavicin, Alexandr A. Myasnikov, Tatyana I. Ionova, PhD, Vladimir J. Melnichenko, MD, PhD, Denis A. Fedorenko, MD, PhD, Anton V. Kishtovich, PhD, Roman A. Ivanov, PhD, Gary J. Gorodokin, MD
Journal: Blood
Blood (2007) 110 (11): 5093.
https://doi.org/10.1182/blood.V110.11.5093.5093
Published: 2007
Journal Articles

Multicenter Experience of High Dose Chemotherapy (HDCT)+Autologous Stem Cell Transplantation (ASCT) in Multiple Sclerosis (MS) Patients.

Yury L. Shevchenko, Andrei A. Novik, Alexey N. Kuznetcov, Boris V. Afanasiev, Igor A. Lisukov, Oleg A. Rykavicin, Alexandr A. Myasnikov, Tatiana I. Ionova, PhD, Sergey V. Shamanski, MD,PhD, Andrey D. Kulagin, MD,PhD, Olga A. Malysheva, MD, Nikolay I. Baziy, MD,PhD, Vladimir Y. Melnichenko, MD,PhD, Denis A. Fedorenko, MD,PhD, Inna V. Vereschagina, MD, Andrey E. Zdorov, MD, Anton V. Kishtovich, PhD, Roman A. Ivanov, PhD, Yury N. Fedotov, MD,PhD, Gary I. Gorodokin, MD
Journal: Blood
Blood (2006) 108 (11): 3072.
https://doi.org/10.1182/blood.V108.11.3072.3072
Published: 2006